{{Rsnum
|rsid=3181224
|Gene=IL12B
|Chromosome=5
|position=159313842
|Orientation=minus
|GMAF=0.112
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.9 | 19.5 | 79.6
| HCB | 0.0 | 9.5 | 90.5
| JPT | 0.0 | 8.0 | 92.0
| YRI | 2.0 | 17.7 | 80.3
| ASW | 1.8 | 15.8 | 82.5
| CHB | 0.0 | 9.5 | 90.5
| CHD | 0.0 | 8.3 | 91.7
| GIH | 1.0 | 6.9 | 92.1
| LWK | 1.8 | 30.9 | 67.3
| MEX | 5.2 | 27.6 | 67.2
| MKK | 1.9 | 28.2 | 69.9
| TSI | 3.9 | 28.4 | 67.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=23280621
|Title=Nucleotide variation in IL10 and IL12 and their receptors and cervical and vulvar cancer risk: A hybrid case-parent triad and case-control study
}}

{{PMID Auto
|PMID=19956101
|Title=Overview of the Rapid Response data.
|OA=1
}}

{{PMID Auto
|PMID=19956104
|Title=Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium.
|OA=1
}}

{{PMID Auto
|PMID=19956106
|Title=Analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}